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Abstract
 
The Fas (CD95) gene is among critical genetic factors in some autoimmune diseases, which are
characterized by autoantibody (autoAb) productions. In mice, mutations in the Fas gene cause
lymphoproliferation (
 
lpr
 
) which predominantly develops glomerulonephritis, whereas the mu-
tations in human cause autoimmune lymphoproliferative syndrome (ALPS) characterized by
autoimmune hemolytic anemia (AIHA) and thrombocytopenia. Although the mechanism of
antinuclear Ab in Fas-deficient background has been well characterized, that of antierythrocyte
Ab production in ALPS has been still unclear. To investigate this mechanism, we developed a
mouse line by crossing the antierythrocyte antibody transgenic mice (H
 
 
 
L6 mice) and Fas-defi-
cient mice. Although Fas deficiency did not break tolerance of autoreactive B-2 cells in
H
 
 
 
L6 mice, autoreactive B-1 cells in Fas-deficient H
 
 
 
L6 homozygous mice became activated
and differentiated into autoAb-producing cells in mesenteric lymph nodes and lamina propria
of intestine, resulting in severe anemia. In addition, serum levels of interleukin (IL)-10 signifi-
cantly increased in Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 homozygous mice and administration of anti–IL-10 Ab
prevented exacerbation of autoAb production and AIHA. These results suggest that activation
of B-1 cells is responsible for induction of AIHA in Fas-deficient condition and that IL-10
plays a critical role in terminal differentiation of B-1 cells in these mice.
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Introduction
 
Autoimmune diseases are the outcome of complicated in-
flammatory processes in which various cellular and humoral
components are involved. In some autoimmune diseases
such as myasthenia gravis, autoimmune hemolytic anemia
(AIHA), and idiopathic thrombocytopenic purpura, patho-
genic autoAbs produced by B cells primarily mediate the
disorders (1–3). The pathogenic autoAbs directly bind to
membrane-bound antigens and cause autoimmune diseases,
whereas other disease-related autoAbs such as rheumatoid
factor do not directly trigger clinical manifestations (4).
Fas (CD95) and Fas ligand (FasL) genes are among the
critical genetic factors for autoAb production in mice and
human (1, 5, 6). Fas is expressed in a variety of cell types
including activated B cells and T cells, whereas FasL is only
expressed in activated T cells and NK cells. Interaction of
Fas and FasL induces rapid apoptosis and plays a critical role
in homeostasis of peripheral lymphocytes and prevention of
autoimmunity (5, 6). In mice, mutations in Fas and FasL
genes cause lymphoproliferation (
 
lpr
 
) and generalized lym-
phoproliferative disease (
 
gld
 
), respectively (5, 6). MRL/
 
lpr
 
mice develop glomerulonephritis with lymphadenopathy
and splenomegaly, caused by accumulation of CD4
 
 
 
CD8
 
 
 
T cells and production of autoAbs to intracellular antigens
(5). The production of autoAbs was blocked by the specific
expression of transgenic (Tg) Fas on B cells but not on T
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cells in 
 
lpr/lpr
 
 mice (7, 8), suggesting that Fas deficiency in
B cells is responsible for autoAb productions. Several stud-
ies using Ig Tg/
 
lpr
 
 mice have shown that central tolerance
to soluble form of model antigens is partially impaired in
Fas deficiency and that production of disease-associated au-
toAbs, such as anti-DNA Ab, rheumatoid factor, and anti-
Sm Ab is markedly enhanced (9–12). However, it is not
clear whether production of pathogenic autoAbs against
membrane-bound antigens is affected in Fas deficiency.
In humans, mutations in Fas gene cause autoimmune
lymphoproliferative syndrome (ALPS) (13). ALPS patients
uniquely develop AIHA, idiopathic thrombocytopenic
purpura, and autoimmune neutropenia, in addition to the
common symptoms to MRL/
 
lpr
 
 mice (13). Furthermore,
ALPS patients but not MRL/
 
lpr
 
 mice show increased num-
bers of CD5
 
 
 
 B cells and elevated levels of serum IL-10
(13–15). These results suggest that CD5
 
 
 
 B cells and IL-10
may play a role in production of pathogenic autoAbs to
membrane-bound self-antigens.
We have generated several Tg mouse lines (H
 
 
 
L and
H
 
 
 
L) in which almost all B cells have specificity for a
membrane-bound antigen on self-RBC and cause AIHA
(2). As autoreactive B cells are eliminated at the immature
stages in the bone marrow, the number of mature B cells is
markedly decreased in the periphery of these mice. In con-
trast, their peritoneal cavity (PerC) contains autoreactive
B-1 cells, that can be activated to produce autoAb by IL-
10, inducing AIHA (16, 17).
To assess whether production of pathogenic autoAb
against membrane-bound self-antigens is affected in Fas de-
ficiency, we crossed Fas-deficient mice and H
 
 
 
L6 mice.
Autoreactive B-1 cells in Fas-deficient H
 
 
 
L6 homozygous
mice were activated to induce severe anemia. In addition,
serum levels of IL-10 significantly increased in these mice
and administration of anti–IL-10 Ab blocked exacerbation
of autoAb production and anemia. These results suggest
that activation of B-1 cells, triggered by IL-10, is responsi-
ble for induction of AIHA in Fas-deficient condition.
 
Materials and Methods
 
Tg Mice.
 
We generated several lines of the anti-RBC mAb
(4C8 mAb) Tg (H
 
 
 
L) mice which carried tandem joined H and
L chain transgenes (18). By mating H
 
 
 
L6 heterozygous mice
and Fas-deficient mice (19), we obtained Fas-deficient H
 
 
 
L6
homozygous mice. The genotype was determined by PCR of
tail DNA. The PCR primers were described previously (18, 19).
The homozygosity of the transgene was screened by Southern
analysis. The mice were maintained under conventional con-
ditions in our animal facility and were analyzed at 8–12 wk
of age.
 
Detection of Anti-RBC AutoAb Production.
 
The amounts of
autoAbs on RBCs were measured as described previously (20).
 
Preparation of Single Cell Suspensions.
 
Isolation of lamina pro-
pria (LP) lymphocytes from the small intestine and preparation of
cells from bone marrow, mesenteric lymph nodes (MLNs), and
PerC were done as described previously (20).
 
Flow Cytometry.
 
Flow cytometric analysis was performed by a
FACSCalibur™ with CELLQuest™ software version 3.1 (Bec-
ton Dickinson) as described previously (20). After excluding dead
cells by propidium iodide gating, cells present in the lymphocyte
gate defined by forward and side light scatters were analyzed.
 
Enzyme-linked Immunospot Assay and Cytoplasmic Staining.
 
Enzyme-linked immunospot (ELISPOT) assay and cytoplasmic
staining were performed on freshly isolated cells from lymphoid
organs as described previously (20).
 
Cytokine ELISA.
 
The levels of serum IL-4, IL-5, IL-6, and
IL-10 were assessed using the mouse IL-4–, IL-5–, IL-6–, and
IL-10–ELISA systems (Amersham Pharmacia Biotech) according
to the manufacturer’s protocol.
 
Administration of Anti–Mouse IL-10 Ab.
 
Either rat anti–
mouse IL-10 mAb (100 
 
 
 
g/injection; Genzyme) or control rat
IgG (100 
 
 
 
g/injection; BD PharMingen) was injected intraperi-
toneally into 4-wk-old Fas-deficient H
 
 
 
L6 homozygous mice
weekly for 4 wk.
 
Results
 
Fas Deficiency Markedly Enhances AutoAb Production and
Anemia in H
 
 
 
L6 Homozygous Mice.
 
To assess how auto-
immunity for membrane-bound autoantigens develops in
Fas deficiency, we crossed H
 
 
 
L6 mice with Fas
 
 
 
/
 
 
 
 mice
and compared the phenotypes of H
 
 
 
L6 heterozygous or
homozygous mice. In H
 
 
 
L6 mice, the size of Tg B-1 cell
compartment in PerC is larger in homozygous than het-
erozygous as described previously (18). As bacterial infec-
tion and/or normal bacterial flora can induce autoAb pro-
duction of B-1 cells in H
 
 
 
L mice (2) and conventional
conditions represent the situations that ALPS patients are
exposed in daily life, we bred H
 
 
 
L6 mice under conven-
tional conditions.
First, we examined the amount of the autoAb bound to
circulating RBCs by flow cytometry and the incidence of
anemia by measuring hematocrit (Ht) values of the periph-
eral blood (Fig. 1). Neither the level of the autoAb nor the
Ht values was changed between Fas
 
 
 
/
 
 
 
 and Fas
 
 
 
/
 
 
 
 H
 
 
 
L6
heterozygous mice. In contrast, a small amount of the au-
toAb was detected in Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 homozygous mice
and their Ht values were slightly reduced compared with
Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 heterozygous mice. More importantly, in
Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 homozygous mice, the amount of the au-
toAb was markedly increased and Ht values were drastically
reduced. These results indicate that Fas deficiency enhances
autoAb production and causes severe anemia in only
H
 
 
 
L6 homozygous mice.
 
Localization of Autoreactive B Cells and AutoAb-producing
Cells in H
 
 
 
L6 Homozygous Mice Carrying Fas Deficiency.
 
As H
 
 
 
L6 homozygous mice contain a larger population of
autoreactive B-1 cells than H
 
 
 
L6 heterozygous mice, it is
possible that B-1 cells may be involved in the autoAb pro-
duction in these mice. To examine the localization of au-
toreactive B cells, we stained cells in bone marrow, spleen,
MLNs, PerC, and LP of the gut with the anti-IgM and
anti-idiotype (S54) Abs and analyzed them by flow cytom-
etry. As both anti-IgM and anti-idiotype Abs stain determi-
nants on the same Ig molecule, the Tg B cells which ex-
press both Tg IgH and IgL on their surface were stained
tight diagonal as described previously (10, 18, 21). Thus, 
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this allows cleaner recognition and enumeration of truly
autoreactive B cells.
A significant number of IgM
 
 
 
S54
 
 
 
 cells, expressing
Mac-1 (data not shown), were observed in PerC of H
 
 
 
L6
homozygous mice, and their compartment was much larger
in H
 
 
 
L6 homozygous than in heterozygous mice (Fig. 2
A). Importantly, although IgM
 
 
 
S54
 
 
 
 cells were slightly in-
creased in PerC of Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 heterozygous mice
compared with the Fas
 
 
 
/
 
 
 
 mice, the IgM
 
 
 
S54
 
 
 
 cells were
significantly reduced in Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 homozygous mice
compared with the Fas
 
 
 
/
 
 
 
 mice. Neither bone marrow or
spleen contained distinct IgM
 
 
 
S54
 
 
 
 cells in H
 
 
 
L6 ho-
mozygous mice (Fig. 2 B), because of clonal deletion of au-
toreactive B-2 cells as described previously (18). In con-
trast, both MLNs and LP in Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 homozygous
mice had a small but significant number of IgM
 
 
 
S54
 
 
 
 cells.
Taken together, the absence of B-2 cells in the periphery
and the decrease of B-1 cells in PerC with concomitant ap-
pearance of IgM
 
 
 
S54
 
 
 
 cells in MLNs and LP are in parallel
with the observation we described previously (20). Thus,
these results strongly suggest that the autoreactive B-1 cells
in PerC may have migrated to MLNs and LP and differen-
tiated into plasma cells in Fas
 
 
 
/
 
 
 
 
 
 
 
 H
 
 
 
L6 homozygous
mice. Staining of IgM
 
 
 
S54
 
 
 
 cells in MLNs and LP differs
from that in PerC. This is probably because of lower sur-
face Ig expression on Ig-secreting cells in MLNs and LP.
To show where the autoAb is produced in Fas
 
 
 
/
 
 
 
 
 
 
 
H L6 homozygous mice, we measured the numbers of
autoAb-producing cells in the bone marrow, spleen,
MLNs, PerC, and LP (Fig. 2 C). As H L6 homozygosity
strongly blocks the rearrangement of endogenous Ig genes,
almost all IgM  cells in these mice express Tg IgM (18).
Therefore, we performed ELISPOT assay using anti-IgM
Ab. Although only small numbers of IgM-producing cells
were observed in Fas /    H L6 homozygous mice, we
Figure 1. Marked enhancement of autoAb production and anemia in
H L6 homozygous mice by Fas deficiency. (A) Amounts of anti-RBC
autoAb bound to circulating RBCs. Peripheral blood RBCs were incu-
bated with FITC-anti–mouse IgM antibody and analyzed by flow cytom-
etry. Closed triangles indicate the mean fluorescence intensity of IgM on
RBCs in individual mice. Horizontal long and short bars indicate the
mean and SD of each group, respectively. (B) Hematocrit values of pe-
ripheral blood. Closed triangles indicate the hematocrit value of individ-
ual mice. Horizontal bars are as described in A. The Student’s t test for
unpaired data was used to compare the values between indicated groups.
Figure 2. Localization of au-
toreactive B cells and autoAb-
producing cells in Fas-deficient
H L6 homozygous mice. (A)
Flow cytometry analysis of PerC
in Fas /  (left panels) or Fas / 
(right panels)   H L6 homozy-
gous, heterozygous, and non-Tg
mice. Cells were stained with
FITC–anti-IgM and biotin-con-
jugated anti-idiotype mAb fol-
lowed by PE-conjugated SA.
The percentages of the cells for a
given phenotype in viable lym-
phocyte gate are shown. (B)
Flow cytometry analysis of bone
marrow (BM), spleen (SPL),
MLN, and LP of Fas /  (left
panels) or Fas /  (right panels)  
H L6 homozygous mice. (C)
Numbers of IgM-producing cells
of Fas /  (white bars) or Fas / 
(black bars)   H L6 homozy-
gous mice in BM, SPL, MLN, PerC, and LP were measured by
ELISPOT assay. The mean and SD of IgM-producing cells per 105 cells
was calculated from at least three mice. (D) Cells were isolated from
MLN, PerC, and LP of Fas /    H L6 homozygous mice, and then
2   105 cells of each were fixed, and stained with FITC-anti–mouse IgM
antibody. Preparations were examined and photographed by fluorescence
microscope. Original magnifications: each panel  400.144 Activation of Anti-RBC B-1 Cells in Fas-deficient Mice
detected large numbers of Ab-producing cells in MLNs
and LP, but not in other organs, of Fas /    H L6 ho-
mozygous mice.
As we found a difference in the distribution between sur-
face Ig expressing cells and IgM-producing cells, we further
confirmed staining pattern and morphology by cytoplasmic
IgM staining. Almost all IgM  cells in PerC of Fas /   
H L6 homozygous mice showed surface staining pattern
of IgM (Fig. 2 D). In contrast, the majority of IgM  cells in
MLNs and LP had typical plasma cell morphology. These
IgM  plasma cells probably have lost some of surface Ig ex-
pression. Taken together, these results suggest that the au-
toreactive PerC B-1 cells may migrate and differentiate in
MLNs and LP. They are also consistent with our previous
observation that the autoAb production predominantly
occurred in MLNs in recombination activating gene
(RAG)2 /    H L mice with activated    T cells (20).
Serum Levels of IL-10 But Not IL-4, IL-5, and IL-6 Are
Significantly Elevated in Fas-deficient H L6 Homozygous
Mice. To examine which cytokine is involved in B-1 cell
migration and terminal differentiation in Fas /    H L6
homozygous mice, serum concentrations of IL-4, IL-5, IL-
6, and IL-10 were assessed by ELISA. The levels of IL-10
but not IL-4, IL-5, and IL-6 were significantly elevated in
Fas /     H  L6 homozygous mice compared with the
other control mice (Fig. 3). Thus, these results suggest that
the elevation of IL-10 may play a critical role in autoreactive
B-1 cell migration and terminal differentiation in Fas /   
H L6 homozygous mice, as described previously (17, 20).
In addition, although the levels of IL-10 in Fas /  non-Tg
mice were not increased (data not shown), the levels of IL-
10 in Fas /    H L6 heterozygous mice were slightly but
significantly increased when compared with Fas /  control
mice. Therefore, the increase of serum IL-10 concentration
closely correlated with the migration and terminal differen-
tiation of autoreactive B-1 cells in Fas deficiency.
Administration of Anti–IL-10 Ab Prevents Exacerbation of
Anemia in Fas-deficient H L6 Homozygous Mice. To test
whether the elevated IL-10 levels play an essential role in
autoAb production in H L6 homozygous mice, we in-
jected the anti–IL-10 mAb into Fas-deficient H L6 ho-
mozygous mice weekly for 4 wk. Injection of anti–IL-10
Ab blocked reduction of Ht values in Fas /    H L6 ho-
mozygous mice compared with control rat IgG injection
(Table I). IL-10 neutralization also suppressed increase in
the amount of anti-RBC Ab and the numbers of autoAb-
producing cells in the MLN of Fas /    H L6 homozy-
gous mice. These results clearly demonstrate that the eleva-
tion of serum IL-10 is responsible for the enhancement of
autoAb production in Fas /    H L6 homozygous mice.
Discussion
In this study, we found marked autoAb production for
RBC membrane Ag in only H L6 homozygous but not in
heterozygous mice under Fas-deficient background. De-
spite the same Ag specificity, higher levels of surface Tg
Figure 3. The serum levels of IL-10, but not IL-4, IL-5, and IL-6 were
elevated in Fas-deficient H L6 homozygous mice. Amounts of IL-4,
IL-5, IL-6, and IL-10 in the serum were assessed in H L6 heterozygous
and homozygous mice with (closed triangles) or without (open triangles)
Fas-deficient background by ELISA. Horizontal long bars indicate the
minimum detectable levels of each cytokine. The Student’s t test for un-
paired data was used to compare the values between indicated groups.
Table I. Administration of Anti–IL-10 mAb Blocks Exacerbation 
of Anemia in Fas-deficient H L6 Homozygous Mice
Treatments
Hematocrit
values (%)
Amounts of the autoAb
bound to RBCs
(mean fluorescence
intensity)
Ig-producing
cells
(per 105 cells)
Anti–IL-10 37.5   2.5a 494.4   364.2b 235.8   173.1b
Control Ig 31.5   0.5 1,419.2   497.2 660.6   240.2
Either anti–IL-10 mAb or control rat IgG (100  g/injection) was
injected weekly into Fas-deficient H L6 homozygous mice. 4 wk after
the first injection, hematocrit values (%) were measured. Amounts of the
autoAb bound to RBCs were assessed as mean fluorescence intensity of
FITC-conjugated anti-IgM Ab bound to RBCs. Numbers of anti-RBC
Ab-producing cells in MLN were measured by ELISPOT assay using
anti-IgM Ab. Values represent the mean   SD of five mice in each
experimental group. Paired t test values calculated between anti–IL-10
and control rat IgG.
aP   0.01.
bP   0.02.145 Watanabe et al. Brief Definitive Report
immunoglobulin expression of H L6 homozygous mice
results in stronger clonal deletion of autoreactive B-2 cells
from periphery compared with heterozygous mice. At the
same time, the size of autoreactive B-1 cell compartment in
PerC is larger in homozygous than in heterozygous mice
(18). Thus, our results suggest that B-1 cells are responsible
for autoAb production in Fas-deficient background. In-
deed, in Fas /    H L6 homozygous mice, autoreactive
B-1 cells can efficiently migrate and differentiate into
plasma cells (Fig. 2, A–D). In contrast, in H L6 heterozy-
gous mice, Fas deficiency did not alter the size of the B-1
cell population (data not shown, and Fig. 2 A).
Because Fas deficiency enhances migration and differen-
tiation but not expansion of autoreactive B-1 cells, second-
ary genetic factors responsible for expansion of B-1 cells
may be required for induction of AIHA. Indeed, genetic
background plays a critical role for autoAb production and
autoimmune diseases in lpr mice and activation of B-1 cells
in PerC (22, 23). In human, additional genetic factors are
also suggested to be involved in lymphoproliferation and
autoimmunity in ALPS (24).
Although we have shown that the serum levels of IL-10
were significantly elevated in Fas /    H L6 homozy-
gous mice, we could not identify a particular cell popula-
tion as the main source of IL-10 in vivo. Our preliminary
experiments of intracellular cytokine staining suggested that
not only B-1 cells but also aberrant T cells and macro-
phages in PerC of H L6 homozygous mice can produce
significant amount of IL-10 by ex vivo stimulation (un-
published data). Indeed, in ALPS patients, aberrant
CD4 CD8  T cells with activated phenotypes accumulate
in peripheral lymphoid organs and can produce large
amounts of IL-10 (15). B-1 cells can also produce IL-10
(25, 26). In addition, we previously showed that both acti-
vated T cells and macrophages are involved in increased se-
rum levels of IL-10 and in migration and differentiation of
peritoneal B-1 cells (17, 20). Thus, aberrant T cells, autore-
active B-1 cells, and macrophages may cooperate in eleva-
tion of IL-10, resulting in activation of autoreactive B-1
cells in Fas-deficient condition.
How IL-10 induces activation of autoreactive B-1 cells is
not yet clear. In vivo role of IL-10 in murine B cell func-
tion is limited (27). However, several previous studies sug-
gest that IL-10 is important for B-1 cell expansion and acti-
vation (23, 28, 29). We have also shown that IL-10
elevation induced by LPS administration or IL-10 adminis-
tration itself can induce autoAb production and anemia in
H L mice (16, 17). However, we could not detect direct
effects of IL-10 for proliferation or differentiation of au-
toreactive B-1 cells (17). Furthermore, we did not find
anti-apoptotic effect for B-1 cells in PerC against RBC in-
jection in Fas /    H L6 homozygous mice (data not
shown). On the other hand, Fas-deficient background
markedly enhances migration and differentiation of autore-
active B-1 cells to not only MLNs but also LP in H L6
homozygous mice, whereas autoreactive B-1 cells in
RAG2 /    H L mice with activated   T cells predom-
inantly migrate into MLNs but not LP (20). Thus, Fas defi-
ciency may help autoreactive B-1 cells to terminally differ-
entiate and migrate into LP, escaping from rapid apoptosis.
Recently, Balabanian et al. have shown that IL-10 increases
the effects of stromal cell–derived factor-1 on the prolifera-
tion and survival of B-1 cells in PerC and that IL-10 is
chemokinetic for peritoneal B-1 cells, increasing their ran-
dom mobility (30). Thus, these effects of IL-10 may play
a role in indirect activation of autoreactive B-1 cells of
Fas /    H L6 homozygous mice.
In summary, we have shown that autoreactive B-1 cells
in PerC migrate into MLNs and LP and differentiate into
Ab-producing cells with Fas-deficient background. Elevated
IL-10 levels are involved in the activation of autoreactive B-1
cells. These results are in parallel with the observation that
ALPS patients with AIHA manifest increased numbers of
CD5  B cells and elevated serum levels of IL-10, implying
that blocking of IL-10 signals may become a therapeutic ap-
proach to autoimmune diseases in ALPS patients.
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